T. Podona

发表

3,4‐Dihydro‐3‐amino‐2H‐1‐benzopyran Derivatives as 5‐HT1A Receptor Ligands and Potential Anxiolytic Agents. Part 1. Synthesis and Structure‐Activity Relationship Studies.

P. Renard, D. Caignard, B. Pfeiffer, 1994 .

Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge.

H. Tapiero, N. Savaraj, T. Lampidis, 1997, Biochemistry.

Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators.

L. Danober, O. Diouf, P. Lestage, 2008, Bioorganic & medicinal chemistry.

4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology,

J Delarge, P Lebrun, M. Spedding, 1998, Journal of medicinal chemistry.

Synthesis and structural studies of a new class of heterocyclic compounds: 1,2,4-Pyridothiadiazine 1,1-dioxides, pyridyl analogues of 1,2,4-benzothiadiazine 1,1-dioxides

P. Tullio, O. Diouf, B. Masereel, 1995 .

Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluation.

O. Diouf, P. Renard, B. Masereel, 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Synthesis and Biological Evaluation of New 3‐Aralkylamino‐2‐aryl‐2H‐1,2,4‐pyridothiadiazine 1,1‐dioxides as Potential CCK‐Receptor Ligands

P. Tullio, O. Diouf, P. Renard, 1997, The Journal of pharmacy and pharmacology.

Synthesis and Structural Studies of a New Class of Heterocyclic Compounds: 1,2,4-Pyridothiadiazine 1,1-Dioxides, Pyridyl Analogues of 1,2,4-Benzothiadiazine 1,1-Dioxides.

P. Tullio, O. Diouf, B. Masereel, 2010 .

3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships.

O. Diouf, B. Masereel, B. Pirotte, 1996, Journal of medicinal chemistry.

3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].

P. Renard, M. Rettori, D. Caignard, 1996, Journal of medicinal chemistry.

3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.

P. Renard, D. Caignard, B. Pfeiffer, 1994, Journal of medicinal chemistry.

Methoxy and hydroxy derivatives of 3,4-dihydro-3-(di-n-propylamino)-2H-1-benzopyrans: new synthesis and dopaminergic activity

A. Gharib, G. Guillaumet, D. Reynaud, 1991 .

Methoxy and Hydroxy Derivatives of 3,4-Dihydro-3-(di-n-propylamino)-2H- 1-benzopyrans: New Synthesis and Dopaminergic Activity.

A. Gharib, G. Guillaumet, D. Reynaud, 1991 .

Brevetoxin derivatives that inhibit toxin activity.

D. Baden, L. Fieber, K. Rein, 2000, Chemistry & biology.

Synthesis and structural studies of a new class of heterocyclic compounds: 1,2,4-Pyridothiadiazine 1,1-dioxides, pyridyl analogues of 1,2,4-benzothiadiazine 1,1-dioxides

P. Tullio, O. Diouf, B. Masereel, 1995 .